RT Journal Article
SR Electronic
T1 Investigating the Causal Link Between Serum Iron Status and Pernicious Anaemia Risk: A Mendelian Randomisation Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.28.24316258
DO 10.1101/2024.10.28.24316258
A1 Cimadevila, Guillermo Comesaña
A1 Thain, Alfie
A1 Dib, Marie-Joe
A1 Ahmadi, Kourosh R
YR 2024
UL http://medrxiv.org/content/early/2024/10/29/2024.10.28.24316258.abstract
AB Introduction Pernicious anaemia (PA) is characterised by vitamin B12 deficiency due to autoimmune-mediated destruction of gastric parietal cells and the consequent loss of intrinsic factor. A considerable proportion of PA patients also exhibit iron deficiency (ID), both before or at (20.7-52%) and after (46.4%) PA diagnosis. However, findings from observational studies do not clarify whether ID contributes to PA risk or is a consequence of the PA disease process. Given the high prevalence of ID at PA diagnosis, we hypothesised that reduced iron status may play a causal role in PA risk.Methodology We conducted two-sample Mendelian Randomisation (MR) analyses to evaluate the causal effect between systemic iron status and PA risk. Genetic association data for iron status were sourced from the deCODE study. Additionally, PA-relevant associative data with the chosen SNPs were obtained from genome-wide-association-study (GWAS) summary statistics, primarily from R10 FinnGen release and from the GWAS conducted by Laisk et al. (2021) for replication purposes. Participant data consisted of 3,694 cases of PA and 393,684 controls. Inverse-variance weighted analysis was the primary MR method, with sensitivity analyses including Egger, and weighted-median estimates, additionally to testing for horizontal pleiotropy and heterogeneity.Results Four SNPs were strongly associated with systemic iron status and were used as genetic instruments. We found that genetically predicted iron status was not significantly associated with PA risk (odds ratio per 1 standard deviation increase in serum iron: 1.13, 95% confidence interval 0.80-1.58, P=0.49). Sensitivity analyses had consistent results, indicating that MR assumptions were not violated and highlighting a null result subjectivity due to the presence of horizontal pleiotropy and heterogeneity.Conclusion This is the first MR study investigating the potential causal relationship between iron status and PA risk. Our results show that genetically predicted iron status is not associated with a significantly increased PA risk among individuals of European ancestry. Further research is needed to understand the manifestation of ID in PA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the University of Surrey. AT is supported by a joint Pernicious Anaemia Society and University of Surrey studentship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:r10 FinnGen release "Vitamin B12 Deficiency Anaemia summary statistics: https://r10.finngen.fi/pheno/D3_ANAEMIA_B12_DEF Results from Bell et al. (2021) GWAS: https://www.nature.com/articles/s42003-020-01575-z Results from Laisk et al. (2021) GWAS: https://www.nature.com/articles/s41467-021-24051-6I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript